Abstract: A highly sensitive indirect atomic absorption spectrophotometric (AAS) method has been developed for the determination of very low concentrations of ciprofloxacin, amoxycillin and diclofenac sodium. The method is based on the oxidation of these drugs with iron(III). The excess of iron(III) was extracted into diethyl ether and then the iron(II) in the aqueous layer was aspirated into an air-acetylene flame and determined by AAS. The linear concentration ranges were 25-400, 50-500 and 60-600 ng ml -1 for ciprofloxacin, amoxycillin and diclofenac sodium, respectively. The results were statistically compared with the official method using t-and f-test at p < 0.05. There were insignificant interferences from most of the excipients present. The intra-and inter-day assay coefficients of variation were less than 6.1 % and the recoveries ranged from 95 to 103 %. The method was applied for the analysis of these drug substances in their commercial pharmaceutical formulations.
INTRODUCTION
Ciprofloxacin, chemically 1,4-dihydro-1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid (Fig. 1a) , is a quinolone antibiotic drug with a broad spectrum of activity against a variety of gram positive and gram-negative bacteria. It is mainly used to treat respiratory infections (Klebsiella pneumoniae, Pseudomonas aeruginosa, Haemophilus influenzae), urinary tract infections, for gastrointestinal surgery, typhoid fever, gonorrhoea b (enterotoxigenic strains of Escherichia coli), and septicaemia. Ciprofloxacin acts by inhibiting the 570 ISSA et al. bacterial enzymes DNA gyrase. Amoxycillin (Fig. 1b) is the only phenolic penicillin used as an antibacterial drug. It is a moderate-spectrum β-lactam antibiotic used to treat bacterial infections caused by susceptible microorganisms. Amoxycillin is susceptible to degradation by β-lactamase-producing bacteria and so may be administered together with clavulanic acid to decrease its susceptibility. Diclofenac sodium is described as the salt of 2-[(2,6-dichlorophenyl)amino]benzene acetic acid (Fig. 1c) . It is a non-steroidal anti-inflammatory drug of the cyclo--oxygenase (COX) inhibitor type. It is used for the treatment of rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis, and for a variety of non-rheumatic inflammatory conditions. Several methods have been reported for the quantitative analysis of the cited drugs, such as spectrophotometry, 1−4 flow injection, 5 fluorimetry, 6 titrimetry, 7, 8 electrophoresis, 9 microbiology, 10, 11 HPLC 12, 13 and AAS 14−16 methods.
The reduction process of iron(III) to iron(II) by certain drugs, such as paracetamol, 17 diclofenac, 18 salbutamol sulphate, 19 captopril, 20 amoxycillin 21 and ciprofloxacin, 21 was used as the basis for their quantification based on a colorimetric method.
The present work aims to develop a highly sensitive, simple and rapid atomic absorption spectrometric method for application in quality control analysis. The proposed method is based on the reduction of iron(III) by the investigated drugs (ciprofloxacin, amoxycillin and diclofenac sodium). The excess of iron(III) was extracted into diethyl ether 22 and then iron(II) in aqueous layer was determined by AAS. The reaction method is simple since it is a single step process.
CIPROFLOXACIN, AMOXYCILLIN AND DICLOFENAC SODIUM

EXPERIMENTAL
Apparatus
The atomic absorption measurements were performed using a Perkin-Elmer AAS, Model A Analyst 100 spectrophotometer equipped with an iron hollow-cathode lamp under the following conditions: wavelength, 302.1 nm; lamp current, 30 mA; slit width, 0.2 nm; air/acetylene ratio, 3.5/1.5. A UV/Vis spectrophotometer (Spectro 23 Labomed Inc. USA) with quartz cells was used for all spectrophotometric measurements.
Chemicals and solutions
Analytical grade ciprofloxacin, amoxycillin and diclofenac sodium standards were obtained from the Middle East Pharmaceutical and Cosmetics Laboratories, Palestine. Various pharmaceutical formulations of ciprofloxacin, amoxycillin and diclofenac sodium were obtained commercially. These formulations contained only the investigated drug and were not in combination with other drugs.
Ferric sulphate was purchased from Sigma. Hydrochloric acid (32 %) was supplied by BDH and diethyl ether by Carlo Erba. Solutions of 2.60×10 -5 M ciprofloxacin (10 µg ml -1 ), 2.38×10 -5 M amoxycillin (10 µg ml -1 ) and 3.14×10 -5 M diclofenac sodium (10 µg ml -1 ) were prepared in 0.10 M HCl. A 1.00×10 -4 M ferric sulphate solution (40 µg ml -1 ) was also prepared in 0.10 M HCl. Standard solutions were prepared by serial dilution. All the employed chemicals were of analytical grade. Deionised water was used for the preparation of all solutions.
Procedure
Six 2.5 ml standard solutions of ciprofloxacin (25-400 ng ml -1 ), amoxycillin (50-500 ng ml -1 ) or diclofenac sodium (60-600 ng ml -1 ) were pipetted into a series of 10 ml volumetric flasks. To each flask, 1.5 ml of 1.0×10 -5 M ferric sulphate was added. The mixtures were heated using a boiling water bath for 10 min (100 °C). After cooling, 4.0 ml of 12 M HCl was added and the excess iron(III) was extracted with three portions of 10 ml of diethyl ether using a separatory funnel. Then the aqueous layer containing iron(II) was aspirated into an air-acetylene flame. The absorbance of iron(II) was measured at 302.1 nm, and the iron concentration was determined from a previously constructed calibration curve.
RESULTS AND DISCUSSION
It was found that ciprofloxacin, amoxycillin and diclofenac sodium were very weak reducing agents at room temperature. The oxidation of these compounds was non-quantitative, slow and time-consuming. However, on heating at 100 °C using a boiling water bath, the given drugs immediately reduced iron(III) to iron(II) in amounts which corresponded to the concentration of the drugs. The amount of iron(II) was determined by AAS.
Response characteristics
The equations of the calibrations describing the relation between drug concentration and atomic absorbance measurements obtained for ciprofloxacin, amoxycillin and diclofenac sodium are summarized as:
Ciprofloxacin where A and c are the absorbance and concentration (in µg ml −1 ) of the drug, respectively. R is the correlation coefficient. The linear concentration ranges were 25-400 ng ml −1 for ciprofloxacin, 50-500 ng ml −1 for amoxycillin and 60-600 ng ml −1 for diclofenac sodium, based on AAS measurements. The proposed method exhibited a high sensitivity for the three drugs, which are 3.1, 4.4 and 4.5 ng ml −1 for ciprofloxacin, amoxycillin and diclofenac sodium, respectively. Comparison of the proposed and official method using the t-test and f-test (p < 0.05) showed the high accuracy and precision of the AAS method. The results obtained by the proposed and official method 23 are summarized in Table I.   TABLE I . Assay of commercial tablet formulations by the AAS method and the official method 23 Official method 23 Proposed The intraday, interday precisions and recoveries were tested (Table II) . These data indicate that the method was reproducible within and between days. The mean percentage recovery ranged from 95 to 103 % (RSD < 6.1 %). The effects of the presence of common excipients (dextrose, glucose, saccharine sodium, starch, talc and magnesium stearate) were tested (Table III) . There were no significant interferences due to the presence of any of these excipients.
Selecting the optimum solvent for an efficient extraction
Several organic solvents were tested to extract Fe(III) in the presence of Fe(II), i.e., 1,2-dichloroethane, chloroform and diethyl ether. To select the suitable solvent, atomic absorbance values caused by the presence of Fe(II) and Fe(III) were measured after extraction with each of the three different organic solvents. The most suitable solvent for the extraction of only Fe(III) in the presence of Fe(II) was diethyl ether. The amount of extracted Fe(III) metal depen-573 ded on the concentration of the acid. The maximum extraction value was attained with ≈ 6 M HCl, where approximately 99.99 % of the iron(III) was extracted. 
Effect of temperature
The effect of the temperature was investigated by heating the reaction mixtures of these drugs in a water bath at different temperatures for 10 min. The absorbance was found to increase with increasing reaction temperature. The maximum absorbance was observed at 100 °C, as shown in Fig. 2 . The time of heating is important to ensure complete reaction. Different heating time intervals were investigated at a constant temperature (100 °C); 10 min was found to be the optimal interval time to achieve complete reaction, as is shown in Fig. 3 . Fig. 2 . Effect of temperature on the oxidation reactions of the drugs, ciprofloxacin 0.4 µg ml -1 , amoxycillin 0.5 µg ml -1 , and diclofenac sodium 0.3 µg ml -1 . Fig. 3 . Effect of heating time on the oxidation reactions of the drugs, ciprofloxacin 0.4 µg ml -1 , amoxycillin 0.5 µg ml -1 , and diclofenac sodium 0.3 µg ml -1 .
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Effect of pH
The effect of pH on the response of the oxidation reactions was determined by recording the absorption of ciprofloxacin (400 ng ml −1 ), amoxycillin (500 ng ml −1 ) and diclofenac sodium (300 ng ml −1 ) at different pH values. The absorption vs. pH graph, Fig. 4 , showed the absorbance was almost independent of pH in the range 1.0-2.5 for ciprofloxacin, amoxycillin and diclofenac sodium. 
Iron(III)/Drug mole ratio
For the stoichiometric relation of the oxidation reaction of the drugs, different amounts of iron(III), 0.2-2.5 ml aliquots (1.0×10 −5 M ferric sulphate) were added to 2.5 ml aliquots of solutions of the drugs, 1.19×10 −6 M ciprofloxacin, 1.04×10 −6 M amoxycillin and 1.88×10 −6 M diclofenac sodium. The maximum absorbance was attained with a five-fold, ten-fold and two-fold amount of iron(III) for ciprofloxacin, amoxycillin and diclofenac sodium, respectively (Fig. 5) . Thus, 1.5 ml of a 1×10 −6 M ferric sulphate solution was employed to achieve a constant and maximum absorbance for the three drugs. 
CONCLUSIONS
The AAS method is highly sensitive and, moreover, it can be used for routine analysis of the investigated drugs in raw materials and pharmaceutical formulations. The method is simple and rapid since it is a single step process. The
